DEDUCE: Multi-head attention decoupled contrastive learning to discover cancer subtypes based on multi-omics data

TL;DR

DEDUCE is an unsupervised multi-head attention model that leverages contrastive learning to identify and characterize cancer subtypes from multi-omics data, improving clustering accuracy over existing methods.

Contribution

The paper introduces DEDUCE, a novel model combining symmetric multi-head attention encoders with decoupled contrastive learning for cancer subtype discovery from multi-omics data.

Findings

Outperforms 10 deep learning models on various datasets

Effectively identifies six AML cancer subtypes

Demonstrates the importance of each module through ablation studies

Abstract

Background and Objective: Given the high heterogeneity and clinical diversity of cancer, substantial variations exist in multi-omics data and clinical features across different cancer subtypes. Methods: We propose a model, named DEDUCE, based on a symmetric multi-head attention encoders (SMAE), for unsupervised contrastive learning to analyze multi-omics cancer data, with the aim of identifying and characterizing cancer subtypes. This model adopts a unsupervised SMAE that can deeply extract contextual features and long-range dependencies from multi-omics data, thereby mitigating the impact of noise. Importantly, DEDUCE introduces a subtype decoupled contrastive learning method based on a multi-head attention mechanism to simultaneously learn features from multi-omics data and perform clustering for identifying cancer subtypes. Subtypes are clustered by calculating the similarity between samples in both the feature space and sample space of multi-omics data. The fundamental concept involves decoupling various attributes of multi-omics data features and learning them as contrasting terms. A contrastive loss function is constructed to quantify the disparity between positive and negative examples, and the model minimizes this difference, thereby promoting the acquisition of enhanced feature representation. Results: The DEDUCE model undergoes extensive experiments on simulated multi-omics datasets, single-cell multi-omics datasets, and cancer multi-omics datasets, outperforming 10 deep learning models. The DEDUCE model outperforms state-of-the-art methods, and ablation experiments demonstrate the effectiveness of each module in the DEDUCE model. Finally, we applied the DEDUCE model to identify six cancer subtypes of AML.